FDA Adverse Event Malfunction Summary report: N

ACT-LR CUVETTE ASSAY

MDR report key: 3537302 · Received October 22, 2013

Report

Report Number
2248721-2013-00055
Event Type
Malfunction
Date Received
October 22, 2013
Date of Event
September 10, 2013
Report Date
September 24, 2013
Manufacturer
INTERNATIONAL TECHNIDYNE CORPORATION
Product Code
JBP
PMA / PMN Number
K960749
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
FR
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

(B)(4). METHOD: PROCESS EVAL PERFORMED. CUVETTE DEVICE HISTORY RECORDS REVIEWED AND FOUND TO MEET SPECIFICATIONS. NO RELATED NCRS OR OTHER RELATED ANOMALIES IDENTIFIED FOR THIS PRODUCT LOT. ITC HAS REQUESTED ALL DATA REQUIRED FOR FORM 3500A.

Description of Event or Problem · 1

DISTRIBUTOR REPORTS CUSTOMER COMPLAINT OF LIQUID QUALITY CONTROL (LQC) GENERATING LOW RESULTS WITH USE OF HEMOCHRON JR. ACT-LR CUVETTES. LQC PERFORMED WITH ONE CONTROL LOT GENERATED RESULT OF 79 SECONDS, WHICH WAS BELOW THE PUBLISHED RANGE OF 109-167 SECONDS. ON A SECOND CONTROL LOT THE RESULT WAS 89 SECONDS, WHICH WAS BELOW THE PUBLISHED RANGE OF 109-178. THIS EVENT OCCURRED OUTSIDE THE UNITED STATES. ITC NOTIFIED BY DISTRIBUTOR ON (B)(4) 2013 THAT THE USER FACILITY SUBMITTED A VIGILANCE REPORT TO (B)(6). THE REPORT INDICATED LQC RESULTS WERE OUTSIDE THE PUBLISHED RANGE. THE INABILITY TO PASS LQC WAS OBSERVED ON MULTIPLE ATTEMPTS, WITH SEVERAL INSTRUMENTS, ACT-LR CUVETTE BOXES, LQC LOTS, AND WITHIN SEVERAL DEPTS. THE VIGILANCE REPORT ALLEGED THAT THERE WAS POSTPONEMENT OF CERTAIN INVASIVE PROCEDURES (UNSPECIFIED) AND DIFFICULTIES WITH MONITORING PTS ON EXTRACORPOREAL MEMBRANE OXYGENATION (ECMO). NO SPECIFIC PT RELATED INFO WAS PROVIDED. THE CUSTOMER DID NOT SPECIFY ANY INCIDENTS OF PT INJURY OR HARM IN ASSOCIATION WITH THE COMPLAINT.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
542033 ACT-LR CUVETTE ASSAY JBP INTERNATIONAL TECHNIDYNE CORPORATION

Patients

Seq Age Sex Outcome Treatment
1